Status
Conditions
About
Subjects with Obstructive Sleep Apnea (OSA) are at increased risk of developing cardiometabolic complications, and effective long-term nCPAP treatment significantly reduces the risk of cardiovascular morbidity and mortality.
Full description
Primary outcome:
Incidence of cardiometabolic diseases in subjects with OSA over 9 years.
Secondary outcomes:
Effects of CPAP treatment on cardiometabolic conditions
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
167 participants in 1 patient group
Loading...
Central trial contact
Jamie C Lam, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal